1039 related articles for article (PubMed ID: 17710731)
21. Androgen-receptor blockade enhances pulsatile luteinizing hormone production in late pubertal males: evidence for a hypothalamic site of physiologic androgen feedback action.
Kerrigan JR; Veldhuis JD; Rogol AD
Pediatr Res; 1994 Jan; 35(1):102-6. PubMed ID: 8134186
[TBL] [Abstract][Full Text] [Related]
22. Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome.
Hall JE; Taylor AE; Hayes FJ; Crowley WF
J Endocrinol Invest; 1998 Oct; 21(9):602-11. PubMed ID: 9856414
[TBL] [Abstract][Full Text] [Related]
23. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.
Jonard S; Dewailly D
Hum Reprod Update; 2004; 10(2):107-17. PubMed ID: 15073141
[TBL] [Abstract][Full Text] [Related]
24. Interrelationship between excessive levels of circulating androgens in blood and ovulatory failure.
Parker CR; Mahesh VB
J Reprod Med; 1976 Aug; 17(2):75-90. PubMed ID: 134158
[TBL] [Abstract][Full Text] [Related]
25. [Circadian and ultradian rhythms in gonadotropin secretion: regulation by ovarian steroids].
Rossmanith WG
Geburtshilfe Frauenheilkd; 1991 Aug; 51(8):585-94. PubMed ID: 1936869
[TBL] [Abstract][Full Text] [Related]
26. Neuroendocrine control in polycystic ovary-like syndrome.
Schoemaker J
Gynecol Endocrinol; 1991 Dec; 5(4):277-88. PubMed ID: 1796749
[TBL] [Abstract][Full Text] [Related]
27. Prenatal androgen excess enhances stimulation of the GNRH pulse in pubertal female rats.
Yan X; Yuan C; Zhao N; Cui Y; Liu J
J Endocrinol; 2014 Jul; 222(1):73-85. PubMed ID: 24829217
[TBL] [Abstract][Full Text] [Related]
28. Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls.
Chhabra S; McCartney CR; Yoo RY; Eagleson CA; Chang RJ; Marshall JC
J Clin Endocrinol Metab; 2005 May; 90(5):2810-5. PubMed ID: 15728200
[TBL] [Abstract][Full Text] [Related]
29. Hypothalamic dysfunction.
Marshall JC; Eagleson CA; McCartney CR
Mol Cell Endocrinol; 2001 Oct; 183(1-2):29-32. PubMed ID: 11604221
[TBL] [Abstract][Full Text] [Related]
30. [Pituitary response to GnRH analogue testing in girls with a polycystic ovary syndrome].
Wikiera B; Wasikowa R
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):13-8. PubMed ID: 16704856
[TBL] [Abstract][Full Text] [Related]
31. Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome.
McGee WK; Bishop CV; Bahar A; Pohl CR; Chang RJ; Marshall JC; Pau FK; Stouffer RL; Cameron JL
Hum Reprod; 2012 Feb; 27(2):531-40. PubMed ID: 22114112
[TBL] [Abstract][Full Text] [Related]
32. Effects of electroacupuncture on the kisspeptin-gonadotropin-releasing hormone (GnRH) /luteinizing hormone (LH) neural circuit abnormalities and androgen receptor expression of kisspeptin/neurokinin B/dynorphin neurons in PCOS rats.
Xu G; Zhao X; Li Z; Hu J; Li X; Li J; Chen Y
J Ovarian Res; 2023 Jan; 16(1):15. PubMed ID: 36650561
[TBL] [Abstract][Full Text] [Related]
33. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.
Berga SL; Yen SS
Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984
[TBL] [Abstract][Full Text] [Related]
34. Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator.
Foecking EM; Szabo M; Schwartz NB; Levine JE
Biol Reprod; 2005 Jun; 72(6):1475-83. PubMed ID: 15744016
[TBL] [Abstract][Full Text] [Related]
35. Endocrine-metabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome.
Garmes HM; Tambascia MA; Zantut-Wittmann DE
Gynecol Endocrinol; 2005 Dec; 21(6):317-23. PubMed ID: 16390779
[TBL] [Abstract][Full Text] [Related]
36. [Etiopathogenesis of the polycystic ovary syndrome].
Sciarra F; Toscano V; Tosti-Croce C
Minerva Endocrinol; 1987; 12(3):183-90. PubMed ID: 3116379
[No Abstract] [Full Text] [Related]
37. Hirsutism, virilism, polycystic ovarian disease, and the steroid-gonadotropin-feedback system: a career retrospective.
Mahesh VB
Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E4-E18. PubMed ID: 22028409
[TBL] [Abstract][Full Text] [Related]
38. Accelerated Episodic Luteinizing Hormone Release Accompanies Blunted Progesterone Regulation in PCOS-like Female Rhesus Monkeys (Macaca Mulatta) Exposed to Testosterone during Early-to-Mid Gestation.
Abbott DH; Vepraskas SH; Horton TH; Terasawa E; Levine JE
Neuroendocrinology; 2018; 107(2):133-146. PubMed ID: 29949806
[TBL] [Abstract][Full Text] [Related]
39. Polycystic ovary syndrome in adolescence.
Blank SK; Helm KD; McCartney CR; Marshall JC
Ann N Y Acad Sci; 2008; 1135():76-84. PubMed ID: 18574211
[TBL] [Abstract][Full Text] [Related]
40. Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia?
Levin JH; Carmina E; Lobo RA
Fertil Steril; 1991 Oct; 56(4):635-40. PubMed ID: 1915936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
